| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 6, 2024 | SERA Sera Prognostics, Inc. | Harrison Robert Gardner74 | Chief Information Officer | Sell | 2,138 | $9.02 | $19,284.76 | -1.4% | -1.0% | -54.2% | |
| Mar 6, 2024 | ATEC Alphatec Holdings, Inc. | Marshall Tyson Eliot62 | General Counsel &Corp. Sec. | Sell | 9,225 | $13.16 | $121,401.00 | -3.0% | -27.1% | -17.1% | |
| Mar 6, 2024 | WRBY Warby Parker Inc. | Miller Steven Clive64 | Chief Financial Officer | Sell | 8,708 | $11.88 | $103,451.04 | -4.4% | +39.8% | +76.4% | |
| Mar 6, 2024 | IART Integra Lifesciences Holdings Corp | Davis Robert T. Jr. | EVP &President, Tt | Sell | 8,348 | $36.59 | $305,491.72 | -14.3% | -12.5% | -39.0% | |
| Mar 6, 2024 | IDXX Idexx Laboratories Inc /de | Polewaczyk James F66 | Executive Vice President | Sell | 8,104 | $558.44 | $4,525,596.16 | -18.1% | -11.9% | -23.0% | |
| Mar 6, 2024 | SERA Sera Prognostics, Inc. | Kearney Paul78 | Chief Data Officer | Sell | 1,028 | $9.02 | $9,272.56 | -0.6% | -1.0% | -54.2% | |
| Mar 6, 2024 | SERA Sera Prognostics, Inc. | Jackson Benjamin81 | General Counsel | Sell | 1,856 | $9.02 | $16,741.12 | -1.2% | -1.0% | -54.2% | |
| Mar 6, 2024 | PRCT Procept Biorobotics Corp | Waters Kevin | EVP, CFO | Sell | 3,435 | $46.67 | $160,311.45 | -6.5% | +42.7% | +28.4% | |
| Mar 6, 2024 | SERA Sera Prognostics, Inc. | Aerts Austin77 | Chief Financial Officer | Sell | 444 | $9.02 | $4,004.88 | -0.1% | -1.0% | -54.2% | |
| Mar 6, 2024 | PRCT Procept Biorobotics Corp | Zadno Reza73 | President, CEO | Sell | 9,179 | $46.67 | $428,383.93 | -3.6% | +42.7% | +28.4% | |
| Mar 6, 2024 | SERA Sera Prognostics, Inc. | Boniface John J.55 | Chief Scientific Officer | Sell | 1,664 | $9.02 | $15,009.28 | -0.9% | -1.0% | -54.2% | |
| Mar 6, 2024 | PACB Pacific Biosciences Of California, Inc. | Meline David W | Director | Buy | 40,000 | $4.40 | $176,160.00 | New | -56.9% | -68.9% | |
| Mar 5, 2024 | ATRC Atricure, Inc. | Dahlquist Karl S.69 | Chief Legal Officer | Sell | 8,231 | $37.36 | $307,510.16 | -13.5% | -40.7% | +0.2% | |
| Mar 5, 2024 | IDXX Idexx Laboratories Inc /de | Vandebroek Sophie V. | Director | Sell | 1,404 | $562.98 | $790,427.01 | -53.6% | -11.8% | -21.7% | |
| Mar 5, 2024 | QSI Quantum-Si Inc | Keyes Jeffry R.59 | Chief Financial Officer | Buy | 50,000 | $1.61 | $80,500.00 | New | -6.8% | -13.0% | |
| Mar 5, 2024 | BFLY Butterfly Network, Inc. | Stoica Andrei G53 | Chief Technology Officer | Sell | 12,113 | $1.15 | $13,929.95 | -1.2% | -14.9% | +179.8% | |
| Mar 5, 2024 | COO Cooper Companies, Inc. | Petersmeyer Gary S59 | Director | Sell | 1,000 | $103.51 | $103,506.00 | -15.0% | -6.6% | -9.9% | |
| Mar 5, 2024 | LMAT Lemaitre Vascular Inc | Jasinski Lawrence J62 | Director | Sell | 5,110 | $67.50 | $344,925.00 | -49.0% | +16.5% | +29.0% | |
| Mar 5, 2024 | WRBY Warby Parker Inc. | Miller Steven Clive64 | Chief Financial Officer | Sell | 8,963 | $12.12 | $108,631.56 | -4.8% | +45.5% | +93.9% | |
| Mar 5, 2024 | WRBY Warby Parker Inc. | Blumenthal Neil Harris66 | Co-chief Executive Officer | Sell | 16,731 | $12.12 | $202,779.72 | -57.9% | +45.5% | +93.9% | |
| Mar 5, 2024 | WRBY Warby Parker Inc. | Gilboa David Abraham62 | Co-chief Executive Officer | Sell | 16,731 | $12.12 | $202,779.72 | -57.6% | +45.5% | +93.9% | |
| Mar 5, 2024 | LAB Standard Biotools Inc. | Casdin Partners Master Fund, L.P.53 | Director, 10% Owner | Buy | 251,403 | $2.57 | $646,168.85 | +1.1% | -3.9% | -53.5% | |
| Mar 5, 2024 | TFX Teleflex Inc | Hicks Cameron P68 | Corp. VP &Chief Hr Officer | Sell | 7,401 | $225.00 | $1,665,225.00 | -42.4% | -3.7% | -39.9% | |
| Mar 5, 2024 | AORT Artivion, Inc. | Green Andrew M | VP Regulatory | Sell | 1,160 | $18.72 | $21,717.64 | -2.4% | +26.6% | +36.5% | |
| Mar 5, 2024 | AORT Artivion, Inc. | Getz Matthew A | VP, Human Resources | Sell | 1,157 | $18.72 | $21,661.35 | -2.3% | +26.6% | +36.5% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.